Stockreport

AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs [Yahoo! Finance Canada]

Evolus, Inc.  (EOLS) 
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
PDF The drugmaker has been relying on Skyrizi and Rinvoq ?to counter a drop in Humira sales, which have been facing competition from cheaper biosimilars, or near copies of [Read more]